tradingkey.logo

Hims & Hers Health Inc

HIMS

55.480USD

-1.650-2.89%
Close 06/13, 16:00ETQuotes delayed by 15 min
12.40BMarket Cap
98.42P/E TTM

Hims & Hers Health Inc

55.480

-1.650-2.89%
More Details of Hims & Hers Health Inc Company
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.
Company Info
Ticker SymbolHIMS
Company nameHims & Hers Health Inc
IPO dateSep 09, 2019
Founded at2021
CEOMr. Andrew Dudum
Number of employees1637
Security typeOrdinary Share
Fiscal year-endSep 09
Address2269 Chestnut St
CitySAN FRANCISCO
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code94123
Phone14158510195
Websitehttps://www.forhims.com/
Ticker SymbolHIMS
IPO dateSep 09, 2019
Founded at2021
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
10.22M
-0.03%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
153.19K
-4.05%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
108.67K
-8.65%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
26.63K
--
Mo Elshenawy
Mo Elshenawy
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Nader Kabbani
Mr. Nader Kabbani
Chief Operating Officer
Chief Operating Officer
--
--
Mr. David Wells
Mr. David Wells
Lead Independent Director
Lead Independent Director
--
--
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
--
--
Dr. Delos Cosgrove, M.D.
Dr. Delos Cosgrove, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher D. Payne
Mr. Christopher D. Payne
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
10.22M
-0.03%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
153.19K
-4.05%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
108.67K
-8.65%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
26.63K
--
Mo Elshenawy
Mo Elshenawy
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Nader Kabbani
Mr. Nader Kabbani
Chief Operating Officer
Chief Operating Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Apr 6
Currency: USDUpdated: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
By BusinessUSD
Name
Revenue
Proportion
Online
1.44B
97.39%
Wholesale
38.58M
2.61%
By RegionUSD
Name
Revenue
Proportion
United States
1.48B
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Online
1.44B
97.39%
Wholesale
38.58M
2.61%
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
10.12%
The Vanguard Group, Inc.
8.56%
Dudum (Andrew)
4.75%
Abraham (Jack)
4.33%
Farallon Capital Management, L.L.C.
3.69%
Other
68.56%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
10.12%
The Vanguard Group, Inc.
8.56%
Dudum (Andrew)
4.75%
Abraham (Jack)
4.33%
Farallon Capital Management, L.L.C.
3.69%
Other
68.56%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
24.19%
Investment Advisor
24.12%
Hedge Fund
15.80%
Individual Investor
11.09%
Research Firm
7.56%
Pension Fund
1.21%
Bank and Trust
0.67%
Venture Capital
0.42%
Private Equity
0.35%
Other
14.58%
Institutional Shareholding
Updated: Tue, Mar 4
Updated: Tue, Mar 4
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
793
190.18M
88.28%
-32.20M
2024Q4
739
195.19M
91.41%
-9.62M
2024Q3
627
167.49M
80.36%
-35.34M
2024Q2
588
165.89M
79.48%
-12.74M
2024Q1
503
156.70M
75.98%
-10.05M
2023Q4
463
153.90M
75.37%
-26.71M
2023Q3
444
160.41M
78.97%
-33.55M
2023Q2
426
173.15M
85.66%
-3.29M
2023Q1
404
156.26M
77.80%
-6.84M
2022Q4
367
141.36M
70.68%
-24.61M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
27.63M
12.92%
+14.33M
+107.76%
Dec 31, 2024
The Vanguard Group, Inc.
20.22M
9.46%
+1.98M
+10.86%
Dec 31, 2024
Dudum (Andrew)
10.61M
4.96%
-2.79K
-0.03%
Mar 18, 2025
Abraham (Jack)
9.32M
4.36%
-2.62M
-21.93%
Dec 31, 2023
Farallon Capital Management, L.L.C.
8.38M
3.92%
+8.36M
+64.34K%
Dec 31, 2024
Goldman Sachs & Company, Inc.
5.19M
2.43%
+4.29M
+474.88%
Dec 31, 2024
State Street Global Advisors (US)
7.77M
3.64%
+3.15M
+68.01%
Dec 31, 2024
Renaissance Technologies LLC
6.95M
3.25%
+1.56M
+28.99%
Dec 31, 2024
Geode Capital Management, L.L.C.
4.33M
2.03%
+40.45K
+0.94%
Dec 31, 2024
View more
Related ETFs
Updated: Fri, Jun 6
Updated: Fri, Jun 6
Name
Proportion
Global X HealthTech ETF
5.9%
Fidelity Digital Health ETF
4.4%
Innovator IBD 50 Fund ETF
4.23%
YieldMax Ultra Option Income Strategy ETF
3.94%
VanEck Social Sentiment ETF
3.68%
Amplify Weight Loss Drug & Treatment ETF
3.5%
Invesco S&P MidCap 400 Pure Growth ETF
3.43%
SPDR S&P Health Care Services ETF
3.33%
First Trust Nasdaq Lux Digi Health Solutions ETF
2.96%
Amplify Online Retail ETF
2.72%
View more
Global X HealthTech ETF
Proportion5.9%
Fidelity Digital Health ETF
Proportion4.4%
Innovator IBD 50 Fund ETF
Proportion4.23%
YieldMax Ultra Option Income Strategy ETF
Proportion3.94%
VanEck Social Sentiment ETF
Proportion3.68%
Amplify Weight Loss Drug & Treatment ETF
Proportion3.5%
Invesco S&P MidCap 400 Pure Growth ETF
Proportion3.43%
SPDR S&P Health Care Services ETF
Proportion3.33%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion2.96%
Amplify Online Retail ETF
Proportion2.72%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI